TSRO Insider Trading
TSRO | Market Equity
Comprehensive Trading Performance Summary
The investment history of corporate insiders at TSRO provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2018-09-26 01:00 | 2018-09-24 | Huber Martin H. Jr. | Officer - SVP & Chief Medical Officer | OPT+S | $37.63 | 371 | $13,961 | 12,206 | 0.0% |
| 2018-09-06 00:04 | 2018-09-04 | Oliveira Orlando | Officer - SVP & GM, International | OPT+S | $32.44 | 72 | $2,336 | 10,254 | 0.0% |
| 2018-08-09 21:00 | 2018-08-07 | ORONSKY ARNOLD L | Director | OPT+S | $26.77 | 10,000 | $267,721 | 2,479 | 0.0% |
| 2018-08-04 00:00 | 2018-08-01 | Farmer Joseph L | Officer - Sr VP, Gen Counsel & Secretary | OPT+S | $34.37 | 187 | $6,427 | 8,292 | 0.0% |
| 2018-06-14 23:14 | 2018-06-12 | Alleva Lawrence M | Director | OPT+S | $43.11 | 7,142 | $307,920 | 29,902 | 0.0% |
| 2018-03-10 01:14 | 2018-03-08 | Oliveira Orlando | Officer - SVP & GM, International | SELL | $69.88 | 3,000 | $209,640 | 9,076 | -24.8% |
| 2018-03-07 05:20 | 2018-03-02 | MOTT DAVID M | Director, 10% owner | BUY | $57.40 | 145,532 | $8,354,177 | 739,516 | +24.5% |
| 2018-03-07 05:19 | 2018-03-02 | NEW ENTERPRISE ASSOCIATES 13 LP | 10% owner | BUY | $57.40 | 116,445 | $6,684,479 | 9,681,129 | +1.2% |
| 2018-03-07 05:17 | 2018-03-02 | SANDELL SCOTT D | 10% owner | BUY | $57.40 | 145,532 | $8,354,177 | 739,516 | +24.5% |
| 2018-03-07 05:16 | 2018-03-02 | Viswanathan Ravi | 10% owner | BUY | $57.40 | 145,532 | $8,354,177 | 739,516 | +24.5% |
| 2018-03-07 05:11 | 2018-03-02 | KERINS PATRICK J | 10% owner | BUY | $57.40 | 116,445 | $6,684,479 | 9,681,129 | +1.2% |
| 2018-03-07 05:11 | 2018-03-02 | BASKETT FOREST | 10% owner | BUY | $57.40 | 145,532 | $8,354,177 | 739,516 | +24.5% |
| 2018-03-07 05:10 | 2018-03-02 | BARRIS PETER J | 10% owner | BUY | $57.40 | 145,532 | $8,354,177 | 739,516 | +24.5% |
| 2018-03-07 05:10 | 2018-03-02 | BARRETT M JAMES | 10% owner | BUY | $57.40 | 116,445 | $6,684,479 | 9,681,129 | +1.2% |
| 2018-03-06 01:27 | 2018-03-01 | Bogle Grant C. | Officer - Sr. VP, Chief Commercial Ofc. | OPT+S | $54.85 | 1,809 | $99,224 | 4,431 | 0.0% |
| 2018-03-06 01:26 | 2018-03-02 | Farmer Joseph L | Officer - Sr.VP,Gen.Counsel & Secretary | OPT+S | $54.86 | 2,634 | $144,501 | 7,854 | 0.0% |
| 2018-03-06 01:25 | 2018-03-02 | Huber Martin H. Jr. | Officer - SVP & Chief Medical Officer | OPT+S | $54.86 | 1,803 | $98,913 | 11,327 | 0.0% |
| 2018-03-06 01:25 | 2018-03-02 | Oliveira Orlando | Officer - SVP & GM, International | OPT+S | $54.86 | 337 | $18,488 | 12,076 | 0.0% |
| 2018-03-06 01:24 | 2018-03-01 | Hedley Mary Lynne | Director, Officer - President & COO | OPT+S | $54.86 | 3,855 | $211,485 | 14,998 | 0.0% |
| 2018-03-06 01:23 | 2018-03-02 | PEARSON TIMOTHY R | Officer - Exec. VP, CFO | OPT+S | $54.86 | 2,575 | $141,265 | 6,211 | 0.0% |
| 2018-03-05 14:05 | 2018-03-02 | MOULDER LEON O JR | Director, Officer - Chief Executive Officer | BUY | $56.93 | 5,000 | $284,640 | 5,000 | +100.0% |
| 2017-12-06 02:10 | 2017-12-04 | Huber Martin H. Jr. | Officer - SVP & Chief Medical Officer | OPT+S | $85.24 | 829 | $70,664 | 7,272 | 0.0% |
| 2017-09-26 00:44 | 2017-09-22 | Huber Martin H. Jr. | Officer - SVP & Chief Medical Officer | OPT+S | $118.60 | 592 | $70,211 | 6,351 | 0.0% |
| 2017-09-21 00:28 | 2017-09-18 | Armitage James O | Director | OPT+S | $117.13 | 10,000 | $1,171,288 | 0 | 0.0% |
| 2017-09-07 04:13 | 2017-09-05 | Oliveira Orlando | Officer - SVP & GM, International | OPT+S | $132.66 | 71 | $9,419 | 6,555 | 0.0% |
| 2017-09-07 04:12 | 2017-09-01 | Bogle Grant C. | Officer - Sr. VP, Chief Commercial Ofc. | OPT+S | $135.00 | 14,167 | $1,912,545 | 293 | 0.0% |
| 2017-09-07 04:00 | 2017-09-06 | English Edward C | Officer - VP of Finance & Administration | OPT+S | $134.92 | 10,862 | $1,465,459 | 396 | 0.0% |
| 2017-06-09 00:18 | 2017-06-06 | English Edward C | Officer - VP of Finance & Administration | OPT+S | $138.65 | 8,500 | $1,178,520 | 396 | 0.0% |
| 2017-04-05 01:16 | 2017-04-03 | Huber Martin H. Jr. | Officer - SVP & Cheif Medical Officer | OPT+S | $153.02 | 829 | $126,854 | 5,693 | 0.0% |
| 2017-03-09 01:17 | 2017-03-06 | English Edward C | Officer - V.P. of Finance & Admin. | OPT+S | $178.06 | 10,000 | $1,780,600 | 396 | 0.0% |
| 2017-03-04 01:19 | 2017-03-02 | PEARSON TIMOTHY R | Officer - Exec. VP, CFO | OPT+S | $177.61 | 1,447 | $257,002 | 2,928 | 0.0% |
| 2017-03-04 01:18 | 2017-03-02 | Oliveira Orlando | Officer - SVP & GM, International | OPT+S | $177.61 | 249 | $44,225 | 5,376 | 0.0% |
| 2017-03-04 01:17 | 2017-03-02 | Huber Martin H. Jr. | Officer - Sr. VP, Chief Medical Officer | OPT+S | $177.61 | 1,428 | $253,627 | 4,772 | 0.0% |
| 2017-03-04 01:16 | 2017-03-02 | Hedley Mary Lynne | Director, Officer - President & COO | OPT+S | $177.61 | 3,927 | $697,474 | 6,073 | 0.0% |
| 2017-03-04 01:16 | 2017-03-02 | Farmer Joseph L | Officer - Sr VP,Gen. Counsel & Secretary | OPT+S | $177.61 | 1,449 | $257,357 | 3,819 | 0.0% |
| 2017-03-04 01:15 | 2017-03-02 | English Edward C | Officer - VP of Finance & Administration | OPT+S | $177.61 | 229 | $40,673 | 396 | 0.0% |
| 2017-03-04 01:15 | 2017-03-02 | Bogle Grant C. | Officer - Sr VP,Chief Commercial Officer | OPT+S | $177.61 | 1,447 | $257,002 | 3,155 | 0.0% |
| 2017-01-04 02:35 | 2017-01-03 | Huber Martin H. Jr. | Officer - SVP & Chief Medical Officer | SELL | $136.26 | 190 | $25,889 | 0 | -100.0% |
| 2016-12-15 00:17 | 2016-12-12 | English Edward C | Officer - VP of Finance and Admin. | OPT+S | $129.05 | 10,000 | $1,290,470 | 0 | 0.0% |
| 2016-11-04 01:27 | 2016-11-02 | Huber Martin H. Jr. | Officer - SVP & Chief Medical Officer | SELL | $121.29 | 327 | $39,662 | 1,515 | -17.8% |
| 2016-09-24 03:50 | 2016-09-22 | Huber Martin H. Jr. | Officer - SVP & Chief Medical Officer | OPT+S | $108.12 | 408 | $44,113 | 842 | 0.0% |
| 2016-09-10 00:01 | 2016-09-08 | English Edward C | Officer - V.P.Finance and Administration | OPT+S | $88.54 | 7,000 | $619,803 | 0 | 0.0% |
| 2016-09-01 23:59 | 2016-08-30 | Hanke Jeffrey H. | Officer - Executive VP, R&D and CSO | OPT+S | $86.04 | 29,166 | $2,509,443 | 0 | 0.0% |
| 2016-07-02 00:47 | 2016-06-30 | Hanke Jeffrey H. | Officer - Executive VP, R&D and CSO | OPT+S | $74.35 | 12,500 | $929,321 | 0 | 0.0% |
| 2016-06-14 16:11 | 2016-06-10 | English Edward C | Officer - VP of Finance & Administration | OPT+S | $40.75 | 7,000 | $285,274 | 0 | 0.0% |
| 2016-03-19 00:41 | 2016-03-18 | Weller Harry R | 10% owner | BUY | $35.19 | 1,420,858 | $49,999,993 | 710,429 | +100.0% |
| 2016-03-19 00:40 | 2016-03-18 | Viswanathan Ravi | 10% owner | BUY | $35.19 | 1,420,858 | $49,999,993 | 710,429 | +100.0% |
| 2016-03-19 00:40 | 2016-03-18 | SANDELL SCOTT D | 10% owner | BUY | $35.19 | 1,420,858 | $49,999,993 | 710,429 | +100.0% |
| 2016-03-19 00:39 | 2016-03-18 | MOTT DAVID M | Director, 10% owner | BUY | $35.19 | 1,420,858 | $49,999,993 | 710,429 | +100.0% |
| 2016-03-19 00:39 | 2016-03-18 | KOLLURI KRISHNA KITTU | 10% owner | BUY | $0.00 | 1,420,858 | $0 | 710,429 | +100.0% |
How to Interpret $TSRO Trades
Not every insider transaction in TSRO is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $TSRO shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for TSRO
Insider activity data for TSRO is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $TSRO, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.